Metabolic control of the cell cycle

Cell Cycle

Volumn 14, Issue 21, 2015, Pages 3379-3388

  Kalucka, Joanna ^a,b   Missiaen, Rindert ^a,b   Georgiadou, Maria ^a,b,c   Schoors, Sandra ^a,b   Lange, Christian ^a,b   De Bock, Katrien ^a,b   Dewerchin, Mieke ^a,b   Carmeliet, Peter ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

Author keywords

Angiogenesis; Cell cycle; Endothelial cell; Metabolism; Quiescence

Indexed keywords

ENZYME; FRUCTOSE 2,6 BISPHOSPHATASE; FRUCTOSE 2,6 BISPHOSPHATASE 3; NOTCH RECEPTOR; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; 6 PHOSPHOFRUCTO 2 KINASE; CELL CYCLE PROTEIN; DLL4 PROTEIN, HUMAN; PFKFB3 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL METABOLISM; CELL PLASTICITY; CELL PROLIFERATION; ENDOTHELIUM CELL; GLYCOLYSIS; HUMAN; METABOLIC REGULATION; METABOLISM; NONHUMAN; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; ENERGY METABOLISM; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSFECTION; GENETICS; PHENOTYPE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; ENERGY METABOLISM; G1 PHASE CELL CYCLE CHECKPOINTS; GLYCOLYSIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PHENOTYPE; PHOSPHOFRUCTOKINASE-2; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84959458924     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1090068     Document Type: Article

References (74)

1. Buchakjian MR, Kornbluth S. The engine driving the ship: metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol 2010; 11:715–27. PMID:20861880; http://dx.doi.org/10.1038/nrm2972
2. Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 2011; 27:441–64. PMID:21985671; http://dx.doi.org/10.1146/annurevcellbio-092910-154237
3. Lemons JM, Feng XJ, Bennett BD, Legesse-Miller A, Johnson EL, Raitman I, Pollina EA, Rabitz HA, Rabinowitz JD, Coller HA. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol 2010; 8:e1000514. PMID:21049082; http://dx.doi.org/10.1371/journal. pbio.1000514
4. Coller HA. Cell biology. The essence of quiescence. Science 2011; 334:1074–5. PMID:22116874; http://dx. doi.org/10.1126/science.1216242
5. O’Farrell PH. Quiescence: early evolutionary origins and universality do not imply uniformity. Philos Trans R Soc Lond B Biol Sci 2011; 366:3498–507. PMID:22084377; http://dx.doi.org/10.1098/rstb. 2011.0079
6. Foster DA, Yellen P, Xu L, Saqcena M. Regulation of G1 cell cycle progression: Distinguishing the restriction point from a nutrient-sensing cell growth checkpoint (s). Genes Cancer 2010; 1:1124–31. PMID:21779436; http://dx.doi.org/10.1177/1947601910392989
7. Pardee AB. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci U S A 1974; 71:1286–90. PMID:4524638; http://dx.doi.org/10.1073/pnas.71.4.1286
8. Tudzarova S, Colombo SL, Stoeber K, Carcamo S, Williams GH, Moncada S. Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-beta-TrCP, sequentially regulate glycolysis during the cell cycle. Proc Natl Acad Sci U S A 2011; 108:5278–83. PMID:21402913; http://dx.doi.org/10.1073/pnas. 1102247108
9. Almeida A, Bolanos JP, Moncada S. E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc Natl Acad Sci U S A 2010; 107:738–41. PMID:20080744; http://dx. doi.org/10.1073/pnas.0913668107
10. Colombo SL, Palacios-Callender M, Frakich N, Carcamo S, Kovacs I, Tudzarova S, Moncada S. Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells. Proc Natl Acad Sci U S A 2011; 108:21069–74. PMID:22106309; http://dx.doi.org/10.1073/pnas. 1117500108
11. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 2008; 18:54–61. PMID:18387799; http://dx.doi.org/10.1016/j.gde. 2008.02.003
12. Westermann B. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol 2010; 11:872–84. PMID:21102612; http://dx.doi.org/10.1038/nrm3013
13. Reinecke F, Smeitink JA, van der Westhuizen FH. OXPHOS gene expression and control in mitochondrial disorders. Biochim Biophy Acta 2009; 1792:1113–21. PMID:19389473; http://dx.doi.org/10.1016/j.bbadis.2009.04.003
14. Chatre L, Ricchetti M. Prevalent coordination of mitochondrial DNA transcription and initiation of replication with the cell cycle. Nucleic Acids Res 2013; 41:3068–78. PMID:23345615; http://dx.doi.org/10.1093/nar/gkt015
15. Katajisto P, Döhla J, Chaffer CL, Pentinmikko N, Marjanovic N, Iqbal S, Zoncu R, Chen W, Weinberg RA, Sabatini DM. Stem cells. Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness. Science 2015; 348:340–43. PMID:25837514; http://dx.doi.org/10.1126/science. 1260384
16. Cornell R, Grove GL, Rothblat GH, Horwitz AF. Lipid requirement for cell cycling. The effect of selective inhibition of lipid synthesis. Exp Cell Res 1977; 109:299–307. PMID:913494; http://dx.doi.org/10.1016/0014-4827(77)90009-X
17. Atilla-Gokcumen GE, Muro E, Relat-Goberna J, Sasse S, Bedigian A, Coughlin ML, Garcia-Manyes S, Eggert US. Dividing cells regulate their lipid composition and localization. Cell 2014; 156:428–39. PMID:24462247; http://dx.doi.org/10.1016/j.cell.2013.12.015
18. Singh P, Saxena R, Srinivas G, Pande G, Chattopadhyay A. Cholesterol biosynthesis and homeostasis in regulation of the cell cycle. PloS One 2013; 8:e58833. PMID:23554937; http://dx.doi.org/10.1371/journal. pone.0058833
19. Welti J, Loges S, Dimmeler S, Carmeliet P. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest 2013; 123:3190–200. PMID:23908119; http://dx.doi.org/10.1172/JCI70212
20. Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 1996; 8:805–14. PMID:8939678; http://dx.doi.org/10.1016/S0955-0674(96)80081-0
21. Attwooll C, Lazzerini Denchi E, Helin K. The E2F family: specific functions and overlapping interests. EMBO J 2004; 23:4709–16. PMID:15538380; http://dx.doi.org/10.1038/sj.emboj.7600481
22. Darville MI, Antoine IV, Mertens-Strijthagen JR, Dupriez VJ, Rousseau GG. An E2F-dependent lateserum-response promoter in a gene that controls glycolysis. Oncogene 1995; 11:1509–17. PMID:7478575
23. Darville MI, Rousseau GG. E2F-dependent mitogenic stimulation of the splicing of transcripts from an S phase-regulated gene. Nucleic Acids Res 1997; 25:2759–65. PMID:9207022; http://dx.doi.org/10.1093/nar/25.14.2759
24. Cam H, Balciunaite E, Blais A, Spektor A, Scarpulla RC, Young R, Kluger Y, Dynlacht BD. A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell 2004; 16:399–411. PMID:15525513; http://dx.doi.org/10.1016/j.molcel. 2004.09.037
25. Goto Y, Hayashi R, Kang D, Yoshida K. Acute loss of transcription factor E2F1 induces mitochondrial biogenesis in HeLa cells. J Cell Physiol 2006; 209:923–34. PMID:16972274; http://dx.doi.org/10.1002/jcp. 20802
26. Blanchet E, Annicotte JS, Lagarrigue S, Aguilar V, Clapé C, Chavey C, Fritz V, Casas F, Apparailly F, Auwerx J, et al. E2F transcription factor-1 regulates oxidative metabolism. Nat Cell Biol 2011; 13:1146–52. PMID:21841792; http://dx.doi.org/10.1038/ncb2309
27. Dali-Youcef N, Mataki C, Coste A, Messaddeq N, Giroud S, Blanc S, Koehl C, Champy MF, Chambon P, Fajas L, et al. Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure. Proc Natl Acad Sci U S A 2007; 104:10703–8. PMID:17556545; http://dx.doi.org/10.1073/pnas.0611568104
28. Hsieh MC, Das D, Sambandam N, Zhang MQ, Nahle Z. Regulation of the PDK4 isozyme by the Rb-E2F1 complex. J Biol Chem 2008; 283:27410–7. PMID:18667418; http://dx.doi.org/10.1074/jbc. M802418200
29. Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, et al. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 2006; 26:5449–69. PMID:16809779; http://dx. doi.org/10.1128/MCB.02074-05
30. Tchakarska G, Roussel M, Troussard X, Sola B. Cyclin D1 inhibits mitochondrial activity in B cells. Cancer Res 2011; 71:1690–9. PMID:21343394; http://dx.doi.org/10.1158/0008-5472.CAN-10-2564
31. Goldin N, Arzoine L, Heyfets A, Israelson A, Zaslavsky Z, Bravman T, Bronner V, Notcovich A, Shoshan-Barmatz V, Flescher E. Methyl jasmonate binds to and detaches mitochondria-bound hexokinase. Oncogene 2008; 27:4636–43. PMID:18408762; http://dx.doi.org/10.1038/onc.2008.108
32. Mathupala SP, Ko YH, Pedersen PL. Hexokinase II: cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 2006; 25:4777–86. PMID:16892090; http://dx.doi.org/10.1038/sj.onc.1209603
33. Galluzzi L, Kepp O, Tajeddine N, Kroemer G. Disruption of the hexokinase-VDAC complex for tumor therapy. Oncogene 2008; 27:4633–5. PMID:18469866; http://dx.doi.org/10.1038/onc.2008.114
34. Estevez-Garcia IO, Cordoba-Gonzalez V, Lara-Padilla E, Fuentes-Toledo A, Falfán-Valencia R, Campos-Rodríguez R, Abarca-Rojano E. Glucose and glutamine metabolism control by APC and SCF during the G1-to-S phase transition of the cell cycle. J Physiol Biochem 2014; 70:569–81. PMID:24604252; http://dx.doi.org/10.1007/s13105-014-0328-1
35. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2splice isoformof pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452:230–3. PMID:18337823; http://dx. doi.org/10.1038/nature06734
36. Mazurek S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol 2011; 43:969–80. PMID:20156581; http://dx.doi.org/10.1016/j.biocel.2010.02.005
37. Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS, et al. Inhibition of pyruvate kinaseM2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011; 334:1278–83. PMID:22052977; http://dx.doi.org/10.1126/science.1211485
38. Lunt SY, Muralidhar V, Hosios AM, Israelsen WJ, Gui DY, Newhouse L, Ogrodzinski M, Hecht V, Xu K, Acevedo PN, et al. Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. Mol Cell 2015; 57:95–107. PMID:25482511; http://dx.doi.org/10.1016/j.molcel.2014.10.027
39. Lv L, Xu YP, Zhao D, Li FL, Wang W, Sasaki N, Jiang Y, Zhou X, Li TT, Guan KL, et al. Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization. Mol Cell 2013; 52:340–52. PMID:24120661; http://dx.doi.org/10.1016/j. molcel.2013.09.004
40. Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D, Aldape K, Hunter T, Alfred Yung WK, Lu Z. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 2012; 150:685–96. PMID:22901803; http://dx.doi.org/10.1016/j.cell. 2012.07.018
41. Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, Gao X, Aldape K, Lu Z. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature 2011; 480:118–22. PMID:22056988; http://dx.doi.org/10.1038/nature10598
42. Keller KE, Doctor ZM, Dwyer ZW, Lee YS. SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells. Mol Cell 2014; 53:700–9. PMID:24606918; http://dx. doi.org/10.1016/j.molcel.2014.02.015
43. Yalcin A, Clem BF, Simmons A, Lane A, Nelson K, Clem AL, Brock E, Siow D, Wattenberg B, Telang S, et al. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem 2009; 284:24223–32. PMID:19473963; http://dx.doi.org/10.1074/jbc. M109.016816
44. Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev 2006; 20:47–64. PMID:16391232; http://dx.doi.org/10.1101/gad.1384406
45. Yalcin A, Clem BF, Imbert-Fernandez Y, Ozcan SC, Peker S, O’Neal J, Klarer AC, Clem AL, Telang S, Chesney J. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27. Cell Death Dis 2014; 5:e1337. PMID:25032860; http://dx.doi.org/10.1038/cddis.2014.292
46. Colell A, Green DR, Ricci JE. Novel roles for GAPDH in cell death and carcinogenesis. Cell Death Differ 2009; 16:1573–81. PMID:19779498; http://dx.doi.org/10.1038/cdd.2009.137
47. Sen N, Hara MR, Kornberg MD, Cascio MB, Bae BI, Shahani N, Thomas B, Dawson TM, Dawson VL, Snyder SH, et al. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat Cell Biol 2008; 10:866–73. PMID:18552833; http://dx.doi.org/10.1038/ncb1747
48. Carujo S, Estanyol JM, Ejarque A, Agell N, Bachs O, Pujol MJ. Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity. Oncogene 2006; 25:4033–42. PMID:16474839; http://dx.doi.org/10.1038/sj. onc.1209433
49. Sundararaj KP, Wood RE, Ponnusamy S, Salas AM, Szulc Z, Bielawska A, Obeid LM, Hannun YA, Ogretmen B. Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 2004; 279:6152–62. PMID:14630908; http://dx.doi.org/10.1074/jbc. M310549200
50. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011; 146:873–87. PMID:21925313; http://dx.doi.org/10.1016/j.cell. 2011.08.039
51. De Bock K, Georgiadou M, Schoors S, Kuchnio A, Wong BW, Cantelmo AR, Quaegebeur A, Ghesquiere B, Cauwenberghs S, Eelen G, et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 2013; 154:651–63. PMID:23911327; http://dx.doi.org/10.1016/j.cell.2013.06.037
52. De Bock K, Georgiadou M, Carmeliet P. Role of endothelial cell metabolism in vessel sprouting. Cell Metab 2013; 18:634–47. PMID:23973331; http://dx.doi.org/10.1016/j.cmet.2013.08.001
53. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161:1163–77. PMID:12810700; http://dx. doi.org/10.1083/jcb.200302047
54. Schoors S, De Bock K, Cantelmo AR, Georgiadou M, Ghesquiere B, Cauwenberghs S, Kuchnio A, Wong BW, Quaegebeur A, Goveia J, et al. Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. Cell Metab 2014; 19:37–48. PMID:24332967; http://dx.doi.org/10.1016/j.cmet.2013.11.008
55. Schoors S, Bruning U, Missiaen R, Queiroz KC, Borgers G, Elia I, Zecchin A, Cantelmo AR, Christen S, Goveia J, et al. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 2015; 520:192-7. PMID:26245368
56. Ghesquiere B, Wong BW, Kuchnio A, Carmeliet P. Metabolism of stromal and immune cells in health and disease. Nature 2014; 511:167–76. PMID:25008522; http://dx.doi.org/10.1038/nature13312
57. Herbert SP, Stainier DY. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol 2011; 12:551–64. PMID:21860391; http://dx.doi.org/10.1038/nrm3176
58. Andersson ER, Sandberg R, Lendahl U. Notch signaling: simplicity in design, versatility in function. Development 2011; 138:3593–612. PMID:21828089; http://dx.doi.org/10.1242/dev.063610
59. Lewis J. Notch signalling and the control of cell fate choices in vertebrates. Semin Cell Deve Biol 1998; 9:583–9. PMID:9892564; http://dx.doi.org/10.1006/scdb.1998.0266
60. Chitnis AB. The role of Notch in lateral inhibition and cell fate specification. Mol Cell Neurosci 1995; 6:311–21. PMID:8742272; http://dx.doi.org/10.1006/mcne.1995.1024
61. Hellstrom M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P, Alva J, Nilsson AK, Karlsson L, Gaiano N, et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007; 445:776–80. PMID:17259973; http://dx.doi.org/10.1038/nature05571
62. Siekmann AF, Lawson ND. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 2007; 445:781–4. PMID:17259972; http://dx.doi.org/10.1038/nature05577
63. Roca C, Adams RH. Regulation of vascular morphogenesis by Notch signaling. Genes Dev 2007; 21:2511–24. PMID:17938237; http://dx.doi.org/10.1101/gad.1589207
64. Izumi N, Helker C, Ehling M, Behrens A, Herzog W, Adams RH. Fbxw7 controls angiogenesis by regulating endothelial Notch activity. PloS One 2012; 7:e41116. PMID:22848434; http://dx.doi.org/10.1371/journal. pone.0041116
65. Bi P, Kuang S. Notch signaling as a novel regulator of metabolism. Trends Endocrinol Metab 2015; 26 (5):248–55. PMID:25805408
66. Segarra M, Williams CK, Sierra Mde L, Bernardo M, McCormick PJ, Maric D, Regino C, Choyke P, Tosato G. Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth. Blood 2008; 112:1904–11. PMID:18577711; http://dx.doi.org/10.1182/blood-2007-11-126045
67. Locasale JW, Cantley LC. Metabolic flux and the regulation of Mammalian cell growth. Cell Metab 2011; 14:443–51. PMID:21982705; http://dx.doi.org/10.1016/j.cmet.2011.07.014
68. Zhou D, Xue J, Lai JC, Schork NJ, White KP, Haddad GG. Mechanisms underlying hypoxia tolerance in Drosophila melanogaster: hairy as a metabolic switch. PLoS Genet 2008; 4:e1000221. PMID:18927626; http://dx.doi.org/10.1371/journal. pgen.1000221
69. Phng LK, Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev Cell 2009; 16:196–208. PMID:19217422; http://dx.doi.org/10.1016/j.devcel. 2009.01.015
70. Latasa MJ, Cisneros E, Frade JM. Cell cycle control of Notch signaling and the functional regionalization of the neuroepithelium during vertebrate neurogenesis. Int J Dev Biol 2009; 53:895–908. PMID:19598111; http://dx.doi.org/10.1387/ijdb.082721ml
71. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52:2745–56. PMID:4355998; http://dx.doi.org/10.1172/JCI107470
72. Guarani V, Deflorian G, Franco CA, Krüger M, Phng LK, Bentley K, Toussaint L, Dequiedt F, Mostoslavsky R, Schmidt MH, et al. Acetylationdependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature 2011; 473:234–8. PMID:21499261; http://dx.doi.org/10.1038/nature09917
73. Itahana K, Campisi J, Dimri GP. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 2007; 371:21–31. PMID:17634571; http://dx.doi.org/10.1007/978-1-59745-361-5_3
74. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7:575–83. PMID:11329059; http://dx.doi.org/10.1038/87904